ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $8,252,888 | +7.3% | 1,080,221 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $7,691,174 | -15.5% | 1,080,221 | -4.0% | 0.00% | 0.0% |
Q2 2022 | $9,106,711 | -38.4% | 1,125,675 | +5.7% | 0.00% | -33.3% |
Q1 2022 | $14,788,710 | -49.3% | 1,065,469 | +2.6% | 0.00% | -50.0% |
Q4 2021 | $29,144,000 | -11.6% | 1,038,623 | +7.1% | 0.01% | -14.3% |
Q3 2021 | $32,960,000 | -11.8% | 969,709 | +6.0% | 0.01% | -12.5% |
Q2 2021 | $37,382,000 | +38.6% | 914,879 | +36.6% | 0.01% | +33.3% |
Q1 2021 | $26,968,000 | -44.9% | 669,842 | -19.1% | 0.01% | -45.5% |
Q4 2020 | $48,953,000 | +8.7% | 827,880 | -10.6% | 0.01% | -8.3% |
Q3 2020 | $45,020,000 | +1304.2% | 925,761 | +1297.0% | 0.01% | +1100.0% |
Q2 2020 | $3,206,000 | +74.1% | 66,269 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,841,000 | +278.0% | 66,269 | +307.3% | 0.00% | – |
Q4 2019 | $487,000 | -65.0% | 16,269 | -63.8% | 0.00% | – |
Q3 2019 | $1,391,000 | -36.0% | 45,000 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $2,174,000 | – | 45,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Matrix Capital Management Company, LP | 15,115,090 | $419,897,000 | 10.74% |
TIGER MANAGEMENT L.L.C. | 1,115,411 | $30,986,000 | 10.41% |
Robertson Stephens Wealth Management, LLC | 537,095 | $14,920,000 | 5.10% |
VIKING GLOBAL INVESTORS LP | 33,493,708 | $930,455,000 | 4.84% |
Senator Investment Group LP | 3,388,085 | $94,121,000 | 3.41% |
Casdin Capital, LLC | 793,125 | $22,033,000 | 2.34% |
Iron Triangle Partners LP | 150,000 | $4,167,000 | 1.61% |
Aristotle Atlantic Partners, LLC | 370,841 | $10,302,000 | 1.57% |
Crewe Advisors LLC | 93,000 | $2,584,000 | 1.54% |
PERSONAL CFO SOLUTIONS, LLC | 112,916 | $3,137,000 | 1.13% |